Dulaglutide
TIRZSEMA-CVOT
Company n/r · Phase n/r · Completed · Enrollment 887132
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Cohort 1 | Obesity + T2D | n/r | n/r | n/r | n/r |
| Cohort 2 | Obesity + T2D | n/r | n/r | n/r | n/r |
| Cohort 3 | Obesity + T2D | n/r | n/r | n/r | n/r |
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
Dulaglutide
Company n/r · Phase n/r · Completed · Enrollment 887132
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Cohort 1 | Obesity + T2D | n/r | n/r | n/r | n/r |
| Cohort 2 | Obesity + T2D | n/r | n/r | n/r | n/r |
| Cohort 3 | Obesity + T2D | n/r | n/r | n/r | n/r |